1-Tert-butylpiperazine → HCID 66558242, compound
Reaction equation
[CH3:1][CH:2]([N:4]1[C:8]([C:9]2[N:10]=[C:11]3[N:21]([CH:22]=2)[CH2:20][CH2:19][O:18][C:17]2[C:12]3=[CH:13][C:14]([CH:23]=O)=[CH:15][CH:16]=2)=[N:7][CH:6]=[N:5]1)[CH3:3].[C:25]([N:29]1[CH2:34][CH2:33][NH:32][CH2:31][CH2:30]1)([CH3:28])([CH3:27])[CH3:26].[BH3-]C#N.[Na+]>CCO>[C:25]([N:29]1[CH2:34][CH2:33][N:32]([CH2:23][C:14]2[CH:15]=[CH:16][C:17]3[O:18][CH2:19][CH2:20][N:21]4[CH:22]=[C:9]([C:8]5[N:4]([CH:2]([CH3:1])[CH3:3])[N:5]=[CH:6][N:7]=5)[N:10]=[C:11]4[C:12]=3[CH:13]=2)[CH2:31][CH2:30]1)([CH3:28])([CH3:27])[CH3:26]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 4-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.02,6]tetradeca1(14),2,4,10,12-pentaene-13-carbaldehyde (50 mg, 0.16 mmol) in EtOH (5.0 mL) was added 1-tert-butylpiperazine (46 mg, 0.32 mmol) and Ti(Oi-Pr)4 (88 mg, 0.31 mmol). The mixture was stirred at room temperature for 30 min. NaBH3CN (20 mg, 0.32 mmol) was added and the reaction mixture was further stirred at room temperature for overnight. The solid was filtered, and the filtrate was concentrated and purified by reverse phase combiflash eluting with a 0-70% gradient of CH3CN in 0.3% NH4HCO3 to give 108 (16 mg, 25% yield). LCMS (ESI): RT=4.92 min, m/z: 450.4 [M+H+]. 1H NMR (500 MHz, CD3OD): δ 8.41 (d, J=2 Hz, 1H), 7.92 (d, J=3 Hz, 1H), 7.20 (dd, J=8.5 Hz, 2.5 Hz, 1H), 7.00 (d, J=8.5 Hz, 1H), 5.90-5.85 (m, 1H), 4.43-4.51 (m, 4H), 3.47 (s, 2H), 2.51-2.39 (m, 8H), 1.51-1.46 (m, 6H), 0.98 (s, 9H)
Workup
- stirringthe reaction mixture was further stirred at room temperature for overnight
- filtrationThe solid was filtered
- concentrationthe filtrate was concentrated
- custompurified by reverse phase combiflash
- washeluting with a 0-70% gradient of CH3CN in 0.3% NH4HCO3
Sources & evidence
- ORD record
- ord-b93d45ebca8a4934825c63b824a6e8fd
- Source dataset
- uspto-grants-2015_07
- Patent number
- US09090628B2
Reaction notes
Loading…